UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000012333 |
|---|---|
| Receipt number | R000014421 |
| Scientific Title | Expression and functional analyses of immunoreceptors on human blood cells |
| Date of disclosure of the study information | 2014/01/15 |
| Last modified on | 2023/02/24 14:22:47 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Expression and functional analyses of immunoreceptors on human blood cells
Acronym
Functional analyses of human immunoreceptors
Scientific Title
Expression and functional analyses of immunoreceptors on human blood cells
Scientific Title:Acronym
Functional analyses of human immunoreceptors
Region
| Japan |
Condition
Condition
none
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
YES
Objectives
Narrative objectives1
1. To elucidate protein and gene expression of immunoreceptors on human blood cells.
2. To clarify the function of immunoreceptors by utilizing human primary blood cells and estimate the homology of the receptors between human and mouse.
3. To identify a novel immunoreceptor.
Basic objectives2
Others
Basic objectives -Others
molecular biology, Basic research
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Expression and function of immunoreceptors on human blood cells. Identification of a novel immunoreceptor.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Healthy
Key exclusion criteria
Unwilling to apply the study
Target sample size
300
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Akira Shibuya |
Organization
University of Tsukuba
Division name
Department of Immunology, Division of Biomedical Science, Faculty of Medicine
Zip code
Address
1-1-1 Tennodai, Tsukuba Science-City, 305-8575, Japan
TEL
029-853-3281
ashibuya@md.tsukuba.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Satoko Tahara |
Organization
University of Tsukuba
Division name
Department of Immunology, Division of Biomedical Science, Faculty of Medicine
Zip code
Address
1-1-1 Tennodai, Tsukuba Science-City, 305-8575, Japan
TEL
029-853-3281
Homepage URL
tokothr@md.tsukuba.ac.jp
Sponsor or person
Institute
University of Tsukuba
Institute
Department
Personal name
Funding Source
Organization
Create revolutionary technological seeds for science and technology innovation (CREST), Japan science and technology agency (JST)
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 01 | Month | 15 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2013 | Year | 11 | Month | 15 | Day |
Date of IRB
| 2013 | Year | 11 | Month | 15 | Day |
Anticipated trial start date
| 2014 | Year | 01 | Month | 16 | Day |
Last follow-up date
| 2023 | Year | 02 | Month | 22 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We will analyze the expression and function of immunoreceptors by ELISA, FACS, WB, qPCR, and gene sequence method. We will also identify a novel immunoreceptor by gene cloning technics.
Management information
Registered date
| 2013 | Year | 11 | Month | 18 | Day |
Last modified on
| 2023 | Year | 02 | Month | 24 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014421
